ASX-listed Aroa Biosurgery jumps on upbeat results, forecast hike

Aroa Biosurgery

27/10/2021 04:35

** Shares of New Zealand-based Aroa Biosurgery  ARX.AX 
climb as much as 3.5% to A$1.180, their highest level since Oct
11  
    ** The soft tissue repair firm upgrades its FY22 outlook for
product revenue on a constant currency basis to NZ$34 mln-NZ$37
mln ($24.29 mln-$26.43 mln), from previous forecast range of
NZ$30 mln to NZ$33 mln (nFWN2RM1R6)
    ** Co posts H1 FY22 product revenue of NZ$17.2 mln on a
constant currency basis, up 110% 
    ** Around 500,000 shares change hands, compared with the
30-day average of ~430,000 shares 
    ** As of last close, stock up 0.4% so far this year, as
compared with an increase of 13.1% in the ASX All Ordinaries
Index  .AORD  
    
    ($1 = 1.3998 New Zealand dollars)

 (Reporting by Roushni Nair in Bengaluru)
 ((Roushni.Nair@thomsonreuters.com))